Elissa M. Ozanne

Elissa M. Ozanne, PhD

Languages spoken: English

Academic Information

Departments Primary - Population Health Sciences

A decision scientist and health services researcher, Dr. Ozanne’s research focuses on patient-centered use of prevention, screening, and treatment strategies in medicine. Dr. Ozanne serves as principal investigator of several National Cancer Institute (NCI), American Heart Association (AHA), and Patient-Centered Outcomes Research Institute (PCORI) grants studying novel approaches for access to, and evaluation of, patient-centered care. She has published more than 100 articles. Dr. Ozanne is the Co-director of the Graduate Certificate in Population Health Sciences.

Prior to moving to Utah, Dr. Ozanne worked at the Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth, the Institute for Health Policy Studies at the UCSF, and the Institute for Technology Assessment at Massachusetts General Hospital and Harvard Medical School.

Dr. Ozanne earned her Ph.D. from Stanford University in Management Science and Engineering. She received a M.S. in Engineering Economic Systems and a B.S. in Biological Sciences also from Stanford University.

Research Statement

Dr. Elissa Ozanne's primary career goal is to guide effective, patient-centered use of prevention, screening, and treatment strategies in cancer and other contexts. Her research is focused on decision-making, including the developing and testing of clinical decision aids, risk communication methods, cost-effectiveness and risk modeling.

Education History

Undergraduate Stanford University
 BS
Graduate Training Stanford University
 MS
Doctoral Training Stanford University
 PhD
Postdoctoral Training University of California, San Francisco
 Postdoctoral Training
Postdoctoral Training Massachusetts General Hospital
 Postdoctoral Training
Postdoctoral Training Dartmouth-Hitchcock Medical Center
 Postdoctoral Training
Postdoctoral Training Harvard Medical School
 Postdoctoral Training

Selected Publications

Journal Article

  1. Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS (2008). Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol, 191(5), 1308-19.
  2. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS (2008). Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol, 103(10), 2432-42.
  3. Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C (2017). Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. Am J Surg, 213(1), 132-139.e2.
  4. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ (2014). Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med, 160(3), 145.
  5. Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ (2011). Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat, 129(1), 165-73.
  6. Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC (2011). Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat, 129(2), 607-16.
  7. Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne EM (2014). Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat, 143(1), 135-40.
  8. Esserman LJ, Alvarado MD, Howe RJ, Mohan AJ, Harrison B, Park C, O'Donoghue C, Ozanne EM (2014). Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? Breast Cancer Res Treat, 144(2), 371-8.
  9. Ozanne EM, Schneider KH, Soeteman D, Stout N, Schrag D, Fordis M, Punglia RS (2015). onlineDeCISion.org: a web-based decision aid for DCIS treatment. Breast Cancer Res Treat, 154(1), 181-90.
  10. Walsh T, Barr PJ, Thompson R, Ozanne E, O'Neill C, Elwyn (2014). Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review. BMJ (Clinical research ed.), 348, g188.
  11. Ozanne EM, Esserman L (2004). Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Cancer epidemiology, biomarkers & prevention, 13(12), 2043-52.
  12. Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes K (2013). Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer epidemiology, biomarkers & prevention, 22(1), 146-9.
  13. Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle G (2012). Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer, 118(8), 2021-30.
  14. Durand MA, Yen RW, O'Malley AJ, Schubbe D, Politi MC, Saunders CH, Dhage S, Rosenkranz K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, Walling L, Marx CM, Volk RJ, Sepucha K, Ozanne E, Percac-Lima S, Bergin E, Goodwin C, Miller C, Harris C, Barth RJ Jr, Aft R, Feldman S, Cyr AE, Angeles CV, Jiang S, Elwyn (2021). What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata. Cancer, 127(3), 422-436.
  15. Esserman L, Ozanne E, van't Veer (2013). Will early detection for breast cancer ever work?. Clinical chemistry, 59(1), 190-3.
  16. Cohan JN, Ozanne EM, Sewell JL, Hofer RK, Mahadevan U, Varma MG, Finlayson (2016). A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study. Diseases of the colon and rectum, 59(6), 520-8.
  17. Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle G (2009). Patient preferences for the chemoprevention of colorectal cancer. Digestive diseases and sciences, 54(10), 2207-14.
  18. Barnes AJ, Hanoch Y, Miron-Shatz T, Ozanne E (2016). Tailoring risk communication to improve comprehension: Do patient preferences help or hurt?. Health psychology, 35(9), 1007-16.
  19. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman (2009). Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. International journal of cancer, 124(5), 1213-9.
  20. Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia R (2013). Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. Journal of the National Cancer Institute, 105(11), 774-81.
  21. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora (2009). Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. Journal of clinical oncology, 27(2), 214-9.
  22. Brecha FS, Ozanne EM, Esplin J, Stoddard GJ, Nirula R, Huang LC, Cohan J (2020). Patient Willingness to Accept Antibiotic Side Effects to Reduce SSI After Colorectal Surgery. The Journal of surgical research, 261, 417-422.
  23. Cohan JN, Orleans B, Brecha FS, Huang LC, Presson A, Fagerlin A, Ozanne E (2021). Factors Associated With Decision Regret Among Patients With Diverticulitis in the Elective Setting. The Journal of surgical research, 261, 159-166.
  24. Sepucha KR, Ozanne EM, Partridge AH, Moy (2009). Is there a role for decision aids in advanced breast cancer?. Medical decision making, 29(4), 475-82.
  25. Bonner C, Trevena LJ, Gaissmaier W, Han PKJ, Okan Y, Ozanne E, Peters E, Timmermans D, Zikmund-Fisher B (2021). Current Best Practice for Presenting Probabilities in Patient Decision Aids: Fundamental Principles. Medical decision making, 41, 272989X21996328.
  26. Trevena LJ, Bonner C, Okan Y, Peters E, Gaissmaier W, Han PKJ, Ozanne E, Timmermans D, Zikmund-Fisher B (2021). Current Challenges When Using Numbers in Patient Decision Aids: Advanced Concepts. Medical decision making, 41, 272989X21996342.
  27. Sepucha K, Ozanne E, Silvia K, Partridge A, Mulley AG J (2007). An approach to measuring the quality of breast cancer decisions. Patient education and counseling, 65(2), 261-9.
  28. Sepucha K, Ozanne E (2010). How to define and measure concordance between patients' preferences and medical treatments: A systematic review of approaches and recommendations for standardization. Patient education and counseling, 78(1), 12-23.
  29. Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne E (2013). Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters. Patient education and counseling, 93(1), 102-7.
  30. Winn K, Ozanne E, Sepucha (2015). Measuring patient-centered care: An updated systematic review of how studies define and report concordance between patients' preferences and medical treatments. Patient education and counseling, 98(7), 811-21.
  31. Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle G (2010). Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology, 254(3), 793-800.
  32. Barlow DR, Higgins BT, Ozanne EM, Tosteson AN, Pearson A (2016). Cost Effectiveness of Operative Versus Non-Operative Treatment of Geriatric Type-II Odontoid Fracture. Spine, 41(7), 610-7.
  33. Sharib J, Esserman L, Koay EJ, Maitra A, Shen Y, Kirkwood KS, Ozanne E (2020). Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. Surgery, 168(4), 601-609.
  34. Esserman L, Sepucha K, Ozanne E, Hwang E (2004). Applying the neoadjuvant paradigm to ductal carcinoma in situ. Annals of surgical oncology, 11(1 Suppl), 28S-36S.
  35. Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, Thorsen C, Ozanne E (2013). Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Annals of surgical oncology, 20(9), 2873-80.
  36. Hanoch Y, Miron-Shatz T, Rolison JJ, Ozanne (2014). Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy. Psycho-oncology, 23(10), 1142-8.
  37. Sepucha K, Ozanne E, Mulley AG J (2006). Doing the right thing: systems support for decision quality in cancer care. Annals of behavioral medicine, 32(3), 172-8.
  38. Holtzman S, Ozanne E, Carone B, Goldstein MK, Steinke G, Timbs (1999). Decision analysis and Alzheimer disease: three case studies. Genetic testing, 3(1), 71-83.
  39. Lauren BN, Silver ER, Faye AS, Rogers AM, Woo Baidal JA, Ozanne EM, Hur (2021). Predictors of households at risk for food insecurity in the United States during the COVID-19 pandemic. Public health nutrition, 24, 1-19.
  40. Esserman LJ, Ozanne EM, Dowsett M, Slingerland J (2005). Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis. Breast cancer research, 7(6), R1153-8.
  41. Silvia KA, Ozanne EM, Sepucha K (2008). Implementing breast cancer decision aids in community sites: barriers and resources. Health expectations, 11(1), 46-53.
  42. Hanoch Y, Miron-Shatz T, Rolison JJ, Omer Z, Ozanne (2015). Shared decision making in patients at risk of cancer: the role of domain and numeracy. Health expectations, 18(6), 2799-810.
  43. Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha K (2009). Doctor-patient communication about advance directives in metastatic breast cancer. Journal of palliative medicine, 12(6), 547-53.
  44. Ozanne EM, Klemp JR, Esserman L (2006). Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. The breast journal, 12(2), 103-13.
  45. Ozanne EM, Annis C, Adduci K, Showstack J, Esserman (2007). Pilot trial of a computerized decision aid for breast cancer prevention. The breast journal, 13(2), 147-54.
  46. Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes K (2009). Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. The breast journal, 15(2), 155-62.
  47. Drohan B, Ozanne EM, Hughes K (2009). Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. The breast journal, 15 Suppl 1, S46-55.
  48. Ozanne EM, Wittenberg E, Garber JE, Weeks J (2010). Breast cancer prevention: patient decision making and risk communication in the high risk setting. The breast journal, 16(1), 38-47.
  49. Ozanne EM, Soeteman DI, Frank ES, Clarke J, Hassett MJ, Stout NK, Punglia R (2020). Commentary: Creating a patient-centered decision aid for ductal carcinoma in situ. The breast journal, 26(7), 1498-1499.
  50. Ozanne EM, Howe R, Omer Z, Esserman L (2014). Development of a personalized decision aid for breast cancer risk reduction and management. BMC medical informatics and decision making, 14, 4.
  51. Abhyankar P, Volk RJ, Blumenthal-Barby J, Bravo P, Buchholz A, Ozanne E, Vidal DC, Col N, Stalmeier (2013). Balancing the presentation of information and options in patient decision aids: an updated review. BMC medical informatics and decision making, 13 Suppl 2, S6.
  52. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, King J, Lawson ML, Linder SK, Lipkus I, Ozanne E, Peters E, Timmermans D, Woloshin (2013). Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC medical informatics and decision making, 13 Suppl 2, S7.
  53. Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne EM, Elwyn (2014). The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. Journal of medical Internet research, 16(1), e2.
  54. Ozanne EM, O'Connell A, Bouzan C, Bosinoff P, Rourke T, Dowd D, Drohan B, Millham F, Griffin P, Halpern EF, Semine A, Hughes K (2012). Bias in the reporting of family history: implications for clinical care. Journal of genetic counseling, 21(4), 547-56.
  55. Howe R, Miron-Shatz T, Hanoch Y, Omer ZB, O'Donoghue C, Ozanne E (2015). Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation. Journal of genetic counseling, 24(5), 744-51.
  56. Campbell S, Stowe K, Ozanne E (2011). Interprofessional practice and decision support: an organizational framework applied to a mental health setting. Journal of interprofessional care, 25(6), 423-7.
  57. Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan C (2014). Perceived versus objective breast cancer risk in diverse women. Journal of women's health (2002), 23(5), 420-7.
  58. Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur (2015). Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clinical gastroenterology and hepatology, 13(1), 84-90.
  59. Miron-Shatz T, Hanoch Y, Doniger GM, Omer ZB, Ozanne E (2014). Subjective but not objective numeracy influences willingness to pay for BRCA1/2 genetic testing among women. Judgment and decision making, 9(2), 152-8.
  60. Miron-Shatz T, Hanoch Y, Katz BA, Doniger GM, Ozanne E (2015). Willingness to test for BRCA1/2 in high risk women: Influenced by risk perception and family experience, rather than by objective or subjective numeracy?. Judgment and decision making, 10(4), 386-99.
  61. Bravo C, O'Donoghue C, Kaplan CP, Luce J, Ozanne (2014). Can mHealth Improve Risk Assessment in Underserved Populations? Acceptability of a Breast Health Questionnaire App in Ethnically Diverse, Older, Low-Income Women. Journal of health disparities research and practice, 7(4),
  62. Ozanne E (2013). Overdiagnosis and Overtreatment of Breast Cancer: How Can We Promote Informed Patient Choice?. Current breast cancer reports, 5(4), 263-5.
  63. Delaney RK, Sisco-Taylor B, Fagerlin A, Weir P, Ozanne E (2020). A systematic review of intensive outpatient care programs for high-need, high-cost patients. Translational behavioral medicine, 10(5), 1187-1199.
  64. Barr PJ, Forcino RC, Thompson R, Ozanne EM, Arend R, Castaldo MG, O'Malley AJ, Elwyn (2017). Evaluating CollaboRATE in a clinical setting: analysis of mode effects on scores, response rates and costs of data collection. BMJ open, 7(3), e014681.
  65. Alvarado M, Ozanne E, Esserman (2012). Overdiagnosis and overtreatment of breast cancer. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, e40-5.
  66. Omer ZB, Hwang ES, Esserman LJ, Howe R, Ozanne E (2013). Impact of ductal carcinoma in situ terminology on patient treatment preferences. JAMA internal medicine, 173(19), 1830-1.
  67. Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne EM, Greenberg CC, Frank ES, Schrag (2017). Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. JAMA oncology, 3(1), 101-104.
  68. Ozanne EM, Drohan B, Hughes K (2009). Challenges and Improvements in the Identification of Women at High Risk. 20(3), 248-50.
  69. Delaney RK, Pinto NM, Ozanne EM, Stark LA, Pershing ML, Thorpe A, Witteman HO, Thokala P, Lambert LM, Hansen LM, Greene TH, Fagerlin (2021). Study protocol for a randomised clinical trial of a decision aid and values clarification method for parents of a fetus or neonate diagnosed with a life-threatening congenital heart defect. BMJ open, 11(12), e055455.
  70. Rogers AM, Lauren BN, Woo Baidal JA, Ozanne EM, Hur (2021). Persistent effects of the COVID-19 pandemic on diet, exercise, risk for food insecurity, and quality of life: A longitudinal study among U.S. adults. Appetite, 167, 105639.
  71. Pinto NM, Patel A, Delaney RK, Donofrio MT, Marino BS, Miller S, Ozanne EM, Zickmund SL, Karasawa MH, Pershing ML, Fagerlin (2021). Provider insights on shared decision-making with families affected by CHD. Cardiology in the young, 1-8.
  72. Kaplan CP, Karliner L, Lee A, Livaudais-Toman J, Tice JA, Ozanne (2021). Acceptability of an mHealth breast cancer risk-reduction intervention promoting risk assessment, education, and discussion of risk in the primary care setting. mHealth, 7, 54.
  73. Cohan JN, Ozanne EM, Hofer RK, Kelly YM, Kata A, Larsen C, Finlayson (2021). Ileostomy or ileal pouch-anal anastomosis for ulcerative colitis: patient participation and decisional needs. BMC gastroenterology, 21(1), 347.
  74. Delaney RK, Pinto NM, Ozanne EM, Brown H, Stark LA, Watt MH, Karasawa M, Patel A, Donofrio MT, Steltzer MM, Miller SG, Zickmund SL, Fagerlin (2021). Parents' decision-making for their foetus or neonate with a severe congenital heart defect. Cardiology in the young, 32(6), 1-8.
  75. Keane H, Huilgol YS, Shieh Y, Tice JA, Belkora J, Sepucha K, Shibley WP, Wang T, Che M, Goodman D, Ozanne E, Fiscalini AS, Esserman L (2021). Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial. NPJ breast cancer, 7(1), 78.
  76. Baucom KJW, Pershing ML, Dwenger KM, Karasawa M, Cohan JN, Ozanne E (2021). Barriers and Facilitators to Enrollment and Retention in the National Diabetes Prevention Program: Perspectives of Women and Clinicians Within a Health System. Women's health reports (New Rochelle, N.Y.), 2(1), 133-141.
  77. Jones AE, McCarty MM, Brito JP, Noseworthy PA, Cavanaugh KL, Cameron KA, Barnes GD, Steinberg BA, Witt DM, Crossley GH, Passman R, Kansal P, Hargraves I, Schmidt M, Jackson E, Guzman A, Ariotti A, Pershing ML, Herrick J, Montori VM, Fagerlin A, Ozanne EM, STEP-UP AFIB Writing Group (2022). Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study. American heart journal, 248, 42-52.
  78. Delaney RK, Thorpe A, Pinto NM, Ozanne EM, Pershing ML, Hansen LM, Lambert LM, Tanner K, Fagerlin (2023). Parents' quality of life and health after treatment decision for a fetus with severe congenital heart defect. Journal of pediatric nursing, 70, 20-25.
  79. Thorpe A, Delaney RK, Pinto NM, Ozanne EM, Pershing ML, Hansen LM, Lambert LM, Fagerlin (2023). Parents' Psychological and Decision-Making Outcomes following Prenatal Diagnosis with Complex Congenital Heart Defect: An Exploratory Study. MDM policy & practice, 8(2), 23814683231204551.
  80. Jones AE, McCarty MM, Cameron KA, Cavanaugh KL, Steinberg BA, Passman R, Kansal P, Guzman A, Chen E, Zhong L, Fagerlin A, Hargraves I, Montori VM, Brito JP, Noseworthy PA, Ozanne E (2023). Development of Complementary Encounter and Patient Decision Aids for Shared Decision Making about Stroke Prevention in Atrial Fibrillation. MDM policy & practice, 8(1), 23814683231178033.
  81. Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS, Athena Breast Health Network Investigators and Advocate Partners, Esserman L (2024). Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study. NPJ breast cancer, 10(1), 90.
  82. Ozanne EM, Maves K, Tramontano AC, Lynch T, Thompson A, Partridge A, Frank E, Collyar D, Basila D, Pinto D, Hyslop T, Ryser MD, Rosenberg S, Hwang ES, Punglia R (2024). Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25). Breast cancer research, 26(1), 134.
  83. Zhong L, Rodriguez Y, Espinel W, Ozanne EM, Kaphingst K (2024). Investigating genetic counselors' communication with Lynch syndrome patients about cascade testing: Barriers, facilitators, and strategies. Journal of genetic counseling,
  84. Leonard ME, Horns JJ, Allen-Brady K, Ozanne EM, Wallace AS, Brooke BS, Supiano MA, Cohan J (2024). Recurrence of severe diverticulitis is associated with age and birth decade. Journal of gastrointestinal surgery, 28(4), 507-512.

Review

  1. Esserman LJ, Shieh Y, Park JW, Ozanne E (2007). A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert review of molecular diagnostics, 7(5), 533-44.
  2. Chung MK, Fagerlin A, Wang PJ, Ajayi TB, Allen LA, Baykaner T, Benjamin EJ, Branda M, Cavanaugh KL, Chen LY, Crossley GH, Delaney RK, Eckhardt LL, Grady KL, Hargraves IG, True Hills M, Kalscheur MM, Kramer DB, Kunneman M, Lampert R, Langford AT, Lewis KB, Lu Y, Mandrola JM, Martinez K, Matlock DD, McCarthy SR, Montori VM, Noseworthy PA, Orland KM, Ozanne E, Passman R, Pundi K, Roden DM, Saarel EV, Schmidt MM, Sears SF, Stacey D, Stafford RS, Steinberg BA, Youn Wass S, Wright J (2021). Shared Decision Making in Cardiac Electrophysiology Procedures and Arrhythmia Management. Circulation. Arrhythmia and electrophysiology, 14(12), e007958.
  3. Torres Roldan VD, Brand-McCarthy SR, Ponce OJ, Belluzzo T, Urtecho M, Espinoza Suarez NR, Toloza FJK, Thota AD, Organick PW, Barrera F, Liu-Sanchez C, Jaladi S, Prokop L, Ozanne EM, Fagerlin A, Hargraves IG, Noseworthy PA, Montori VM, Brito J (2021). Shared Decision Making Tools for People Facing Stroke Prevention Strategies in Atrial Fibrillation: A Systematic Review and Environmental Scan. Medical decision making, 41(5), 540-549.
  4. Durand MA, Yen RW, O'Malley AJ, Schubbe D, Politi MC, Saunders CH, Dhage S, Rosenkranz K, Weichman K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, Mitchell M, Walling L, Marx C, Volk RJ, Sepucha K, Ozanne E, Percac-Lima S, Bergin E, Goodwin C, Acosta J, Miller C, Harris C, Barth R, Aft R, Feldman S, Cyr AE, Angeles C, Forcino R, Scalia P, Aarts JWM, van den Muijsenbergh M, Jiang S, Elwyn (2021).
  5. Punglia R, Stout N, Cronin A, Uno H, Ozanne E, Hassett M, Frank E, Schrag D, Greenberg C, Soeteman (2020).

Book Chapter

  1. Ozanne EM, Esserman (2010). Decision Making in Breast Cancer Prevention. 7(2-3), 299-311.

Editorial

  1. Ozanne EM, Noseworthy PA, Cameron KA, Schmidt M, Cavanaugh K, Pershing ML, Guzman A, Sivly A, Fagerlin (2020). Shared Decision Making in the Era of Telehealth: Implications for Practice and Research. MDM policy & practice, 5(2), 2381468320976364.

Letter

  1. Ozanne EM, Hwang ES, Esserman L (2007). Letter to the Editor. The breast journal, 13(5), 540.

Abstract

  1. Braithwaite D, Moore D, Liebman M, Belkora J, West D, Satariano W, Ozanne EM, Esserma (2006). New comorbidity model to optimize decisions about interventions for breast cancer patients. Breast cancer research and treatment, 100(Suppl 1),
  2. Braithwaite D, Moore D, West D, Satariano W, Liebman M, Belkora J, Ozanne EM, Esserman (2005). Estimating prognostic impact of comorbidity: Development of a breast cancer specific model. Breast cancer research and treatment, 94(Suppl 1),
  3. Ozanne EM, Sharko J, Drohan B, Grinstein G, Hughes K (2009). Identification of high-risk lesions through automated natural language processing (NLP) of pathology reports; also presented as a poster at the 2008 CTRC-AACR San Antonio Breast Cancer Symposium. Cancer research, 69(2 Suppl), 3001.
  4. Ozanne EM, Cipriano L, Cameron M, Newman T, Esserman L (2009). Cost-effectiveness of surgical interventions for BRCA gene mutation carriers: impact of delaying decision-making; also presented as a poster at the 2008 CTRC-AACR San Antonio Breast Cancer Symposium. Cancer research, 69(2 Suppl), 503.
  5. Thorsen CM, Weiss JE, Kerlikowske K, Ozanne EM, Buist DS, Hubbard RA, Tosteson AN, Henderson LM, Virnig BA, Goodrich ME, Onega T (2012). Impact of preoperative MRI on the surgical treatment of breast cancer: a SEER-Medicare analysis. Cancer research, 72(24 Suppl), P4-01-15.
  6. Alvarado MD, Hayes MT, Sethi R, Ozanne E (2015). NSABP B-43 is unlikely to produce a cost-effective treatment strategy for HER2+ DCIS. Cancer research, 75(9 Suppl), P1-10-03.
  7. Ozanne EM, Stout N, Schneider K, Soeteman D, Schrag D, Fordis M, Punglia (2015). onlineDeCISion.org: An interactive web-based clinical decision aid for DCIS treatment; also presented as a poster at the 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. Cancer research, 75(9 Suppl), P2-10-01.
  8. Alvarado M, Harrison B, Howe R, Rounds K, Solin L, Ozanne E (2012). Cost-effectiveness of gene expression profiling for ductal carcinoma in-situ (Oncotype DCIS Score). Cancer research, 72(24 Suppl), P5-15-01.
  9. Howe R, Omer Z, Hanoch Y, Miron-Shatz T, Thorsen C, Ozanne E (2012). Single nucleotide polymorphism testing for breast cancer risk assessment: Patient trust and willingness to pay. Cancer research, 72(24 Suppl), P4-11-03.
  10. Esserman LJ, Mohan AJ, Park C, Berry D, Ozanne EM, Alvarado M (2011). Projecting the impact of adopting trial results. Cancer research, 71(24 Suppl), PD06-08.
  11. Omer Z, Hwang ES, Esserman L, Ozanne E (2011). Words matter: Influence of DCIS diagnosis terminology on patient treatment decisions. Cancer research, 71(24 Suppl), P5-15-01.
  12. Ozanne EM, Omer Z, Carlson (2011). Automated breast cancer risk assessment: Identifying high risk women in the primary care setting; also presented as a poster at the 34th Annual CTRC'AACR San Antonio Breast Cancer Symposium; Dec 6¿10, 2011; San Antonio, TX. Cancer research, 71(24 Suppl), P4-10-04.
  13. Ozanne EM, Boortz S, Bechtold T, Esserman L (2010). Wide Scale, Automated Breast Cancer Risk Assessment and Decision Support for High Risk Women: www.BreastHealthDecisions.org; also presented as a poster at the 33rd Annual CTRC'AACR San Antonio Breast Cancer Symposium; Dec 8¿12, 2010; San Antonio, TX. Cancer research, 70(24 Suppl), P6-09-11.
  14. Ozanne EM, Cipriano L, Cameron M, Newman T, Esserman L (2009). Cost-effectiveness of genetic testing for BRCA1 and BRCA2 mutations; also presented as a poster at the 2008 CTRC-AACR San Antonio Breast Cancer Symposium. Cancer research, 69(2 Suppl), 6100.
  15. Thompson C, Ekland M, O'Donoghue C, Ozanne EM, Esserman (2015). The aggregate number of false-positive recalls and biopsies performed under different breast cancer screening strategies in the US; also presented as a poster at the 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. Cancer research, 75(9 Suppl), P3-02-01.
  16. Thorsen CM, Eklund M, Ozanne EM, Esserman L (2012). The cost of mammography screening in the United States by screening policy. Cancer research, 72(24 Suppl), P3-02-12.
  17. Ozanne EM, Crawford B, Petruse A, Madlensky L, Weiss L, Hogarth M, Wenger N, Goodman D, Park H, Anton-Culver H, Yasmeen S, Howell L, Ojeda H, Parker B, Kaplan C, van't Veer L, Esserman L, Naeim (2012). Risk assessment and personalized decision support: The University of California Athena Breast Health Network; also presented as a poster at the 35th Annual CTRC'AACR San Antonio Breast Cancer Symposium; Dec 4¿8, 2012; San Antonio, TX. Cancer research, 72(24 Suppl), P4-13-13.
  18. Ozanne EM, Drohan B, Hughes K (2013). Breast cancer risk assessment: How risk models can ¿overdiagnose¿ risk; also presented at the American Society of Clinical Oncology Annual Meeting Quality Care Symposium; November 1-2, 2013. Journal of clinical oncology, 31(31 Suppl), 184.
  19. Howe R, Hassett M, Wheelock A, O'Donoghue CT, Kaplan C, Ozanne E (2012). Cost of cancer care: The impact of disclosure on treatment preferences. Journal of clinical oncology, 30(Suppl 34), 15.
  20. Esserman E, Chu B, Chung R, Ozanne EM, Yau C, Tsing P, Baehner FL, Tutt AN, Moore DH, Benz (2010). Risk partitioning model shows need to address time dependence of breast cancer recurrence¿. Journal of clinical oncology, 28(15 Suppl), 10605.
  21. Alvarado M, Mohan A, Esserman LJ, Ozanne E (2011). Cost-effectiveness of intraoperative radiation therapy for breast conservation. Journal of clinical oncology, 29(15 Suppl), 6081.
  22. Henderson L, Hubbard R, Wernli K, Kerlikowske K, Buist DSM, Sprague B, Goodrich M, DeMartini W, Ozanne E, Zhu W, O'Donoghue C, Virnig BA, Tosteson ANA, Onega (2015). Are breast density and family history associated with pre-operative breast MRI use?. Journal of clinical oncology, 33(15 Suppl), e17543.
  23. Ozanne EM, Esserman (2003). A new breast cancer prevention tool incorporates contextual risk assessment and biomarkers. Journal of clinical oncology,
  24. Ozanne EM, Esserman (2001). Risk Assessment Guidelines for Breast Cancer Prevention Used in a Shared Medical Decision Making Setting; also presented orally at the 23rd Annual Meeting of the Society for Medical Decision Making. Medical decision making, 21(6),

Other

  1. Ozanne E (2003). An analytic approach to medical risk management: Decisions for breast cancer prevention.
  2. Rogers AM, Lauren BN, Woo Baidal JA, Ozanne EM, Hur (2022). Corrigendum to "Persistent effects of the COVID-19 pandemic on diet, exercise, risk for food insecurity, and quality of life: A longitudinal study among U.S. adults" [Appetite 167 (2021) 105639]. Appetite, 168, 105701.